Bellevue Life Sciences Acquisition Corp.
$3.36
+0.00 (+0.00%)
Price as of Oct 15, 2026 market close
Performance
- 1 Month
- +0.0%
- 3 Months
- +0.0%
- YTD
- +0.0%
- 1 Year
- -69.5%
- 3 Year annualized
- -31.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 70.7%
- Largest decline max drawdown, since Feb 2023
- -73.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.14
Own BLACU?
See how BLACU contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.